[go: up one dir, main page]

UY35662A - DERIVATIVES OF SPIROINDOLINE AND PHARMACEUTICAL COMPOSITIONS OF THE SAME - Google Patents

DERIVATIVES OF SPIROINDOLINE AND PHARMACEUTICAL COMPOSITIONS OF THE SAME

Info

Publication number
UY35662A
UY35662A UY35662A UY35662A UY35662A UY 35662 A UY35662 A UY 35662A UY 35662 A UY35662 A UY 35662A UY 35662 A UY35662 A UY 35662A UY 35662 A UY35662 A UY 35662A
Authority
UY
Uruguay
Prior art keywords
spiroindoline
derivatives
pharmaceutical compositions
same
diseases
Prior art date
Application number
UY35662A
Other languages
Spanish (es)
Inventor
Dr Olaf Panknin
Ring Sven
Dr Gernot Langer
Dr Katrin Nowak-Reppel
Original Assignee
Bayer Pharma AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Pharma AG filed Critical Bayer Pharma AG
Publication of UY35662A publication Critical patent/UY35662A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • A61P5/04—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin for decreasing, blocking or antagonising the activity of the hypothalamic hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Derivados de espiroindolina, procesos para su pre paración y composiciones farmacéuticas con los mismos, su uso para el tratamiento de enfermedades y su uso en la elaboración de medicamentos para el tratamiento de enfermedades, en especial enferme dades relacionadas con las hormonas sexuales, tan to en hombres como en mujeres. La presente solicitud se relaciona en particular con derivados de e spiroindolina como antagonistas del receptor de l a hormona liberadora de gonadotropina (GnRH).Spiroindoline derivatives, processes for their preparation and pharmaceutical compositions with them, their use for the treatment of diseases and their use in the preparation of medicines for the treatment of diseases, especially diseases related to sex hormones, so to Men as in women. The present application relates in particular to derivatives of e spiroindoline as antagonists of the gonadotropin releasing hormone (GnRH) receptor.

UY35662A 2013-07-15 2014-07-15 DERIVATIVES OF SPIROINDOLINE AND PHARMACEUTICAL COMPOSITIONS OF THE SAME UY35662A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP13176578 2013-07-15

Publications (1)

Publication Number Publication Date
UY35662A true UY35662A (en) 2015-02-27

Family

ID=48783116

Family Applications (1)

Application Number Title Priority Date Filing Date
UY35662A UY35662A (en) 2013-07-15 2014-07-15 DERIVATIVES OF SPIROINDOLINE AND PHARMACEUTICAL COMPOSITIONS OF THE SAME

Country Status (4)

Country Link
AR (1) AR096905A1 (en)
TW (1) TW201542564A (en)
UY (1) UY35662A (en)
WO (1) WO2015007606A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112717119B (en) * 2021-01-27 2024-04-30 南京羚诺生物医药技术研究院有限公司 Cetrorelix pharmaceutical composition and preparation method thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6200957B1 (en) * 1995-12-14 2001-03-13 Merck & Co., Inc. Antagonists of gonadotropin releasing hormone
EA201491344A1 (en) * 2012-01-16 2015-04-30 Байер Интеллектуэль Проперти Гмбх SPYROINDOLINE DERIVATIVES AS ANTAGONISTS OF THE GORADONE GONADOTROPYN-REALIZING RECEPTOR

Also Published As

Publication number Publication date
WO2015007606A1 (en) 2015-01-22
AR096905A1 (en) 2016-02-03
TW201542564A (en) 2015-11-16

Similar Documents

Publication Publication Date Title
CL2015003395A1 (en) Pyrazolopyrrolidine derivatives and their use in the treatment of disease
CL2017001364A1 (en) New substituted indazoles, procedures for their preparation, pharmaceutical preparations containing them, as well as their use for the preparation of medicines.
CL2016000153A1 (en) Glioxamide substituted pyrrolamide derivatives and their use as medicines for the treatment of hepatitis b
GT201500138A (en) NOVEDOSOUS DERIVATIVES OF BENCIMIDAZOL AS ANTAGONISTS OF EP4
MX2018001721A (en) 5-BROMO-2,6-DI- (1H-PIRAZOL-1-IL) PIRIMIDIN-4-AMINA-FOR USE IN THE TREATMENT OF CANCER.
CL2015002335A1 (en) 2-Aminopyrimidine derivatives for the treatment of viral infections.
GT201400153A (en) DERIVATIVES OF SPIROINDOLINE AS ANTAGONISTS OF THE RECEIVER OF GONADOTROPINE HORMONE LIBERATOR
CL2014003444A1 (en) Thienopyrimidine derivative compounds; Preparation process; pharmaceutical composition that includes them; pharmaceutical combination; use in the treatment of cancers and autoimmune diseases.
UY36779A (en) NEW DERIVATIVES OF EXENDINA-4 AS SPECIFIC DUAL PEPTIDE AGONISTS OF GLP-1 / GLUCAGÓN RECEPTORS
DOP2015000246A (en) DERIVATIVES OF REPLACED OXOPIRIDINE AND USES OF THE SAME IN THE TREATMENT OF CARDIOVASCULAR DISORDERS
MX2017016376A (en) Piperidine derivative and preparation method and pharmaceutical use thereof.
MX2016008131A (en) Bicyclic heterocycle compounds and their uses in therapy.
BR112018070199A2 (en) pharmaceutical composition of steroid hormone
MX379193B (en) SOLID SOLUTION COMPOSITIONS AND THEIR USE IN CHRONIC INFLAMMATION.
AR092925A1 (en) DERIVATIVES OF EXENDINA-4 AS DUAL AGONISTS OF GLP1 / GLUCAGON
MX380829B (en) QUINOXALINE DERIVATIVES USEFUL AS FIBROBLAST GROWTH FACTOR RECEPTOR (FGFR) KINASE BUFFERERS.
BR112015030387A8 (en) pyrazole compounds modulators of fshr, their manufacturing process, pharmaceutical composition that comprises them, as well as their use
UY35455A (en) TRIPEPTIDIC INHIBITORS OF PROTEASA EPOXYCETONE
ECSP16012582A (en) HETEROCYCLIC COMPOUNDS AND METHODS OF USE
SV2018005760A (en) USEFUL AMINOTIAZOL DERIVATIVES AS ANTIVIRICAL AGENTS
DOP2014000114A (en) NOVEL 2HINDAZOLES AS EP2 RECEPTOR ANTAGONISTS
MX2016005142A (en) DERIVATIVES OF PIRAZOLOPIRIMIDONA OR PIRROLOTRIAZONA, METHOD AND PREPARATION OF THE SAME AND PHARMACEUTICAL APPLICATIONS OF THE SAME.
UY37947A (en) IMIDAZOPIRIDINE AMIDAS REPLACED AND ITS USE
UY35771A (en) TIENOURACIL-CYCLIC CARBOXAMIDES AND ITS USE
CL2016001130A1 (en) Solid triglyceride compositions and uses of these

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20211207